Cargando…
Exploring common genetic contributors to neuroprotection from amyloid pathology
Preclinical Alzheimer’s disease describes some individuals who harbour Alzheimer’s pathologies but are asymptomatic. For this study, we hypothesized that genetic variation may help protect some individuals from Alzheimer’s-related neurodegeneration. We therefore conducted a genome-wide association s...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006043/ https://www.ncbi.nlm.nih.gov/pubmed/35425899 http://dx.doi.org/10.1093/braincomms/fcac066 |
_version_ | 1784686588598419456 |
---|---|
author | Seto, Mabel Mahoney, Emily R. Dumitrescu, Logan Ramanan, Vijay K. Engelman, Corinne D. Deming, Yuetiva Albert, Marilyn Johnson, Sterling C. Zetterberg, Henrik Blennow, Kaj Vemuri, Prashanthi Jefferson, Angela L. Hohman, Timothy J. |
author_facet | Seto, Mabel Mahoney, Emily R. Dumitrescu, Logan Ramanan, Vijay K. Engelman, Corinne D. Deming, Yuetiva Albert, Marilyn Johnson, Sterling C. Zetterberg, Henrik Blennow, Kaj Vemuri, Prashanthi Jefferson, Angela L. Hohman, Timothy J. |
author_sort | Seto, Mabel |
collection | PubMed |
description | Preclinical Alzheimer’s disease describes some individuals who harbour Alzheimer’s pathologies but are asymptomatic. For this study, we hypothesized that genetic variation may help protect some individuals from Alzheimer’s-related neurodegeneration. We therefore conducted a genome-wide association study using 5 891 064 common variants to assess whether genetic variation modifies the association between baseline beta-amyloid, as measured by both cerebrospinal fluid and positron emission tomography, and neurodegeneration defined using MRI measures of hippocampal volume. We combined and jointly analysed genotype, biomarker and neuroimaging data from non-Hispanic white individuals who were enrolled in four longitudinal ageing studies (n = 1065). Using regression models, we examined the interaction between common genetic variants (Minor Allele Frequency >0.01), including APOE-ɛ4 and APOE-ɛ2, and baseline cerebrospinal levels of amyloid (CSF Aβ42) on baseline hippocampal volume and the longitudinal rate of hippocampal atrophy. For targeted replication of top findings, we analysed an independent dataset (n = 808) where amyloid burden was assessed by Pittsburgh Compound B ([(11)C]-PiB) positron emission tomography. In this study, we found that APOE-ɛ4 modified the association between baseline CSF Aβ42 and hippocampal volume such that APOE-ɛ4 carriers showed more rapid atrophy, particularly in the presence of enhanced amyloidosis. We also identified a novel locus on chromosome 3 that interacted with baseline CSF Aβ42. Minor allele carriers of rs62263260, an expression quantitative trait locus for the SEMA5B gene (P = 1.46 × 10(−8); 3:122675327) had more rapid neurodegeneration when amyloid burden was high and slower neurodegeneration when amyloid was low. The rs62263260 × amyloid interaction on longitudinal change in hippocampal volume was replicated in an independent dataset (P = 0.0112) where amyloid burden was assessed by positron emission tomography. In addition to supporting the established interaction between APOE and amyloid on neurodegeneration, our study identifies a novel locus that modifies the association between beta-amyloid and hippocampal atrophy. Annotation results may implicate SEMA5B, a gene involved in synaptic pruning and axonal guidance, as a high-quality candidate for functional confirmation and future mechanistic analysis. |
format | Online Article Text |
id | pubmed-9006043 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-90060432022-04-13 Exploring common genetic contributors to neuroprotection from amyloid pathology Seto, Mabel Mahoney, Emily R. Dumitrescu, Logan Ramanan, Vijay K. Engelman, Corinne D. Deming, Yuetiva Albert, Marilyn Johnson, Sterling C. Zetterberg, Henrik Blennow, Kaj Vemuri, Prashanthi Jefferson, Angela L. Hohman, Timothy J. Brain Commun Original Article Preclinical Alzheimer’s disease describes some individuals who harbour Alzheimer’s pathologies but are asymptomatic. For this study, we hypothesized that genetic variation may help protect some individuals from Alzheimer’s-related neurodegeneration. We therefore conducted a genome-wide association study using 5 891 064 common variants to assess whether genetic variation modifies the association between baseline beta-amyloid, as measured by both cerebrospinal fluid and positron emission tomography, and neurodegeneration defined using MRI measures of hippocampal volume. We combined and jointly analysed genotype, biomarker and neuroimaging data from non-Hispanic white individuals who were enrolled in four longitudinal ageing studies (n = 1065). Using regression models, we examined the interaction between common genetic variants (Minor Allele Frequency >0.01), including APOE-ɛ4 and APOE-ɛ2, and baseline cerebrospinal levels of amyloid (CSF Aβ42) on baseline hippocampal volume and the longitudinal rate of hippocampal atrophy. For targeted replication of top findings, we analysed an independent dataset (n = 808) where amyloid burden was assessed by Pittsburgh Compound B ([(11)C]-PiB) positron emission tomography. In this study, we found that APOE-ɛ4 modified the association between baseline CSF Aβ42 and hippocampal volume such that APOE-ɛ4 carriers showed more rapid atrophy, particularly in the presence of enhanced amyloidosis. We also identified a novel locus on chromosome 3 that interacted with baseline CSF Aβ42. Minor allele carriers of rs62263260, an expression quantitative trait locus for the SEMA5B gene (P = 1.46 × 10(−8); 3:122675327) had more rapid neurodegeneration when amyloid burden was high and slower neurodegeneration when amyloid was low. The rs62263260 × amyloid interaction on longitudinal change in hippocampal volume was replicated in an independent dataset (P = 0.0112) where amyloid burden was assessed by positron emission tomography. In addition to supporting the established interaction between APOE and amyloid on neurodegeneration, our study identifies a novel locus that modifies the association between beta-amyloid and hippocampal atrophy. Annotation results may implicate SEMA5B, a gene involved in synaptic pruning and axonal guidance, as a high-quality candidate for functional confirmation and future mechanistic analysis. Oxford University Press 2022-03-17 /pmc/articles/PMC9006043/ /pubmed/35425899 http://dx.doi.org/10.1093/braincomms/fcac066 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Seto, Mabel Mahoney, Emily R. Dumitrescu, Logan Ramanan, Vijay K. Engelman, Corinne D. Deming, Yuetiva Albert, Marilyn Johnson, Sterling C. Zetterberg, Henrik Blennow, Kaj Vemuri, Prashanthi Jefferson, Angela L. Hohman, Timothy J. Exploring common genetic contributors to neuroprotection from amyloid pathology |
title | Exploring common genetic contributors to neuroprotection from amyloid pathology |
title_full | Exploring common genetic contributors to neuroprotection from amyloid pathology |
title_fullStr | Exploring common genetic contributors to neuroprotection from amyloid pathology |
title_full_unstemmed | Exploring common genetic contributors to neuroprotection from amyloid pathology |
title_short | Exploring common genetic contributors to neuroprotection from amyloid pathology |
title_sort | exploring common genetic contributors to neuroprotection from amyloid pathology |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006043/ https://www.ncbi.nlm.nih.gov/pubmed/35425899 http://dx.doi.org/10.1093/braincomms/fcac066 |
work_keys_str_mv | AT setomabel exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT mahoneyemilyr exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT dumitresculogan exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT ramananvijayk exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT engelmancorinned exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT demingyuetiva exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT albertmarilyn exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT johnsonsterlingc exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT zetterberghenrik exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT blennowkaj exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT vemuriprashanthi exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT jeffersonangelal exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT hohmantimothyj exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology AT exploringcommongeneticcontributorstoneuroprotectionfromamyloidpathology |